Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACTRN12619001521112Phase 2Not yet recruiting
Phase 2, randomised, open-label trial in myocardial infarction (MI) comparing Lignocaine with Fentanyl (2 arms). Primary endpoints: Prehospital change in pain score and Composite safety endpoint. Planned start Jan 2020; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ACTRN12619001521112.